|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4166 | (2013.01) |
| A61K 31/196 | (2006.01) | ||
| A61K 31/69 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/196 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 31/192 | (2013.01) | ||
| A61K 31/195 | (2006.01) | ||
| A61K 31/277 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/58 | (2013.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/4196 | (2013.01) | ||
| A61K 31/277 | (2006.01) | ||
| A61K 31/138 | (2013.01) | ||
| A61K 31/4166 | (2006.01) | ||
| A61K 31/5685 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/4196 | (2006.01) | ||
| A61K 31/69 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61K 31/5685 | (2006.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61K 31/138 | (2006.01) |
| (11) | Patento numeris | 3380086 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16869301.8 |
| Europos patento paraiškos padavimo data | 2016-11-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-10-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/063659 |
| Data | 2016-11-23 |
| (87) | Numeris | WO 2017/091762 |
| Data | 2017-06-01 |
| (30) | Numeris | Data | Šalis |
| 201562260098 P | 2015-11-25 | US |
| (72) |
GHIAUR, Gabriel , US
JONES, Richard, J. , US
ALONSO, Salvador , US
CHANDRARATNA, Roshantha, A. , US
|
| (73) |
IO Therapeutics, Inc. ,
9450 Pinecroft Dr., Unit 9497, Spring, TX 77387,
US
The Johns Hopkins University , 3400 North Charles Street, Baltimore, MD 21218, US |
| (54) | CYP26-RESISTANT RAR-ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER |
| CYP26-RESISTANT RAR-ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER |